A strategic partnership has been announced to develop Saudi Arabia’s first fully integrated, modular advanced therapy ...

Some 55 attorneys general (AGs), representing all eligible states and US territories, have agreed to sign on to a $7.4 ...

Australian biotech CSL has announced that the US Food and Drug Administration (FDA) has approved Andembry (garadacimab-gxii), ...

Pharma majors AbbVie and Roche were both trading lower early Tuesday after top-line results were announced from the global ...

Medicines for Europe, a manufacturers of generic and biosimilar trade group, today presented five trade policy ...

US pharma major Eli Lilly (today announced a definitive agreement to acquire Verve Therapeutics, a Boston-based ...

Israel’s Teva Pharmaceutical Industries and Shanghai Fosun Pharmaceutical have entered a strategic partnership for the ...

South Korea’s clinical-stage biotech D&D Pharmatech saw its share leap as much as 30% as it revealed “remarkably positive” ...

US trade association PhRMA (Pharmaceutical Research and Manufacturers of America) has cited a new IQVIA study that found that ...

Shares of USA-based NextCure slumped 26% to $0.50 on Monday, after the company announced a strategic partnership with ...

Cambridge, UK-based Maxion Therapeutics today announced the appointment of Dr Stefan Härtle as chief development officer, ...

Aquestive Therapeutics today announced that the US Food and Drug Administration (FDA) has accepted the company’s New Drug Application (NDA) for Anaphylm sublingual epinephrine film under development ...